{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T23:12:06Z","timestamp":1767136326748,"version":"build-2238731810"},"update-to":[{"DOI":"10.1002\/14651858.cd012056.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,3,30]],"date-time":"2020-03-30T00:00:00Z","timestamp":1585526400000}}],"reference-count":106,"publisher":"Wiley","issue":"3","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd012056.pub3","type":"journal-article","created":{"date-parts":[[2020,3,30]],"date-time":"2020-03-30T08:09:07Z","timestamp":1585555747000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Interventions for preventing and managing advanced liver disease in cystic fibrosis"],"prefix":"10.1002","volume":"2020","author":[{"given":"Senthil K","family":"Palaniappan","sequence":"first","affiliation":[{"name":"NHS trust; Department of Medicine, University Hospitals of Leicester; Leicester Royal Infirmary Leicester UK LE1 5WW"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan Nitra","family":"Than","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Melaka-Manipal Medical College (MMMC), Manipal Academy of Higher Education(MAHE); Department of Community Medicine; Melaka Malaysia 75150"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aung Win","family":"Thein","sequence":"additional","affiliation":[{"name":"Melaka-Manipal Medical College; Department of Surgery; Jalan Batu Hampar, Bukit Baru Melaka Melaka Malaysia 75150"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Indra","family":"van Mourik","sequence":"additional","affiliation":[{"name":"Birmingham Children's Hospital; Liver Unit; Steelhouse Lane Birmingham UK B4 6NH"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2020,3,30]]},"reference":[{"issue":"4","key":"10.1002\/14651858.CD012056.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1542\/peds.80.4.517","article-title":"Taurine improves the absorption of a fat meal in patients with cystic fibrosis","volume":"80","author":"Belli","year":"1987","journal-title":"Pediatrics"},{"key":"10.1002\/14651858.CD012056.pub3-BIB0002|cit2","first-page":"345","article-title":"The effect of treatment with ursodeoxycholic acid in cystic fibrosis and hepatopathy: results of a placebo-controlled study","volume":"Falk Symposium","author":"Bittner","year":"1991","journal-title":"Bile Acids As Therapeutic Agents. From Basic Science to Clinical Practice. Falk Symposium 58."},{"key":"10.1002\/14651858.CD012056.pub3-BIB0003|cit3","unstructured":"Bittner P Seiler T Ott H Posselt H-G Margdorf K Kawinkel M Therapeutical approach of ursodeoxycholic acid in cystic fibrosis and hepatopathy 16th Annual Meeting of the European Working Group for Cystic Fibrosis; 1989; Prague, Czechoslovakia 1989 72"},{"issue":"4","key":"10.1002\/14651858.CD012056.pub3-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1002\/hep.1840160412","article-title":"Ursodeoxycholic acid therapy in cystic fibrosis-associated liver disease: a dose-response study","volume":"16","author":"Colombo","year":"1992","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"43","key":"10.1002\/14651858.CD012056.pub3-BIB0005|cit5","first-page":"349","article-title":"Ursodeoxycholic acid therapy for liver disease associated with cystic fibrosis","volume":"43","author":"Colombo","year":"1991","journal-title":"Bile Acids As Therapeutic Agents. From Basic Science to Clinical Practice. Falk Symposium 58"},{"key":"10.1002\/14651858.CD012056.pub3-BIB0006|cit6","unstructured":"Colombo C Setchell KDR Podda M Crossignani A Assaisso ML Giunta A Ursodeoxycholic Acid (UDCA) in CF associated liver disease (LD): A dose response study 17th European Cystic Fibrosis Conference; 1991 Jun 18-21; Copenhagen, Denmark 1991 140"},{"issue":"Suppl 28","key":"10.1002\/14651858.CD012056.pub3-BIB0007|cit7","first-page":"343","article-title":"Ursodeoxycholic acid for liver disease associated to cystic fibrosis: long-term follow-up of patients enrolled in the Italian multicenter trial","volume":"40","author":"Colombo","year":"2005","journal-title":"Pediatric Pulmonology"},{"issue":"6","key":"10.1002\/14651858.CD012056.pub3-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1002\/hep.510230627","article-title":"Ursodeoxycholic acid for liver disease associated with cystic fibrosis: a double-blind multicenter trial. The Italian Group for the Study of Ursodeoxycholic Acid in Cystic Fibrosis","volume":"23","author":"Colombo","year":"1996","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"10.1002\/14651858.CD012056.pub3-BIB0009|cit9","first-page":"275","article-title":"Treatment with Ursodeoxycholic acid for patients with cystic fibrosis and liver disease","volume":"18","author":"Colombo","year":"1993","journal-title":"Clinical Ecology of Cystic Fibrosis"},{"key":"10.1002\/14651858.CD012056.pub3-BIB0010|cit10","unstructured":"Colombo C Battezzati PM Santini B Lapichino L Quattrucci S Lucidi V Ursodeoxycholic Acid (UDCA) for liver disease associated with cystic fibrosis (CF): a double-blind multicenter trial 18th European Cystic Fibrosis Conference; 1993 May 21-26; Madrid, Spain 1993 W6.1"},{"key":"10.1002\/14651858.CD012056.pub3-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"142A","DOI":"10.1016\/0270-9139(93)92096-I","article-title":"Ursodeoxycholic acid for cystic fibrosis associated liver disease: final report of a multicenter trial","volume":"18","author":"Colombo","year":"1993","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"4 Pt 2","key":"10.1002\/14651858.CD012056.pub3-BIB0012|cit12","first-page":"143A","article-title":"Ursodeoxycholic acid for cystic fibrosis-associated liver disease: Final report of a multicenter trial","volume":"20","author":"Colombo","year":"1994","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"10.1002\/14651858.CD012056.pub3-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1002\/hep.1840360613","article-title":"Liver disease in cystic fibrosis: a prospective study on incidence, risk factors and outcome","volume":"36","author":"Colombo","year":"2002","journal-title":"Hepatology"},{"issue":"6","key":"10.1002\/14651858.CD012056.pub3-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1203\/00006450-198506000-00015","article-title":"Effect of taurine supplements on fat absorption in cystic fibrosis","volume":"19","author":"Darling","year":"1985","journal-title":"Pediatric Research"},{"issue":"3","key":"10.1002\/14651858.CD012056.pub3-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1053\/crad.1999.0077","article-title":"Transjugular intrahepatic portosystemic stent shunt placement in a patient with cystic fibrosis complicated by portal hypertension","volume":"55","author":"Fleet","year":"2000 May","journal-title":"Clinical Radiology"},{"key":"10.1002\/14651858.CD012056.pub3-BIB0016|cit16","unstructured":"Kapustina TJ Kashirskaia NJ Kapranov NI Neudakhin EV Effect of ursodeoxycholic acid on lipid metabolism in patients with cystic fibrosis 13th International Cystic Fibrosis Congress; 2000 Jun 4-8; Stockholm, Sweden 2000 132"},{"issue":"7","key":"10.1002\/14651858.CD012056.pub3-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1155\/2006\/539345","article-title":"Liver transplantation for cirrhosis in cystic fibrosis","volume":"20","author":"Lamireau","year":"2006","journal-title":"Canadian Journal of Gastroenterology"},{"issue":"4 Pt 2","key":"10.1002\/14651858.CD012056.pub3-BIB0018|cit18","first-page":"271A","article-title":"Ursodeoxycholic acid (UDCA) improves essential fatty acid (EFA) deficiency in cystic fibrosis","volume":"18","author":"Lacaille","year":"1993","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"1","key":"10.1002\/14651858.CD012056.pub3-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0022-3476(97)70310-X","article-title":"Ursodeoxycholic acid improves the hepatic metabolism of essential fatty acids and retinol in children with cystic fibrosis","volume":"130","author":"Lepage","year":"1997","journal-title":"Journal of Pediatrics"},{"issue":"2","key":"10.1002\/14651858.CD012056.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/00005176-199408000-00010","article-title":"Effect of a medium dose of ursodeoxycholic acid with or without taurine supplementation on the nutritional status of patients with cystic fibrosis: a randomised, placebo-controlled, crossover trial","volume":"19","author":"Merli","year":"1994","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"issue":"S1","key":"10.1002\/14651858.CD012056.pub3-BIB0021|cit21","first-page":"130","article-title":"Outcome after liver transplantation for cystic fibrosis","volume":"11","author":"Mieles","year":"1991","journal-title":"Pediatric Pulmonology. Supplement"},{"key":"10.1002\/14651858.CD012056.pub3-BIB0022|cit22","first-page":"342","article-title":"Effect of ursodeoxycholic acid (UDCA) therapy for CF liver disease on indirect tests of hepatic function","volume":"Suppl 10","author":"Narkewicz","year":"1994","journal-title":"Pediatric Pulmonology"},{"issue":"6","key":"10.1002\/14651858.CD012056.pub3-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/j.1399-3046.2010.01341.x","article-title":"Isolated liver transplantation in children with cystic fibrosis--an Australian experience","volume":"14","author":"Nightingale","year":"2010","journal-title":"Pediatric Transplantation"},{"issue":"4","key":"10.1002\/14651858.CD012056.pub3-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1136\/adc.71.4.349","article-title":"Liver transplantation for hepatic cirrhosis in cystic fibrosis","volume":"71","author":"Noble-Jamieson","year":"1994","journal-title":"Archives of Disease in Childhood"},{"issue":"10","key":"10.1002\/14651858.CD012056.pub3-BIB0025|cit25","first-page":"857","article-title":"A controlled trial of ursodeoxycholic acid treatment in cystic fibrosis-related liver disease","volume":"4","author":"O'Brien","year":"1992","journal-title":"European Journal of Gastroenterology & Hepatology"},{"key":"10.1002\/14651858.CD012056.pub3-BIB0026|cit26","first-page":"S14","article-title":"Ursodeoxycholic acid treatment in cystic fibrosis related liver disease","volume":"33","author":"O'Brien","year":"1992","journal-title":"Gut"},{"issue":"5","key":"10.1002\/14651858.CD012056.pub3-BIB0027|cit27","first-page":"477","article-title":"Serum bile acids and ursodeoxycholic acid treatment in cystic fibrosis-related liver disease","volume":"8","author":"O'Brien","year":"1996","journal-title":"European Journal of Gastroenterology & Hepatology"},{"key":"10.1002\/14651858.CD012056.pub3-BIB0028|cit28","first-page":"1111","article-title":"Transjugular intrahepatic portosystemic shunt in five children with cystic fibrosis: long-term results","volume":"50","author":"Pozler","year":"2003","journal-title":"Hepatogastroenterology"},{"key":"10.1002\/14651858.CD012056.pub3-BIB0029|cit29","unstructured":"Pukhalsky A Shmarina G Pukhalskaya D Perederko L Whether low frequency of hepatobiliary abnormalities in cystic fibrosis patients is associated with anti-inflammatory treatment? European Respiratory Society Annual Congress; 2008 Oct 4-8; Berlin, Germany. 2008 216s"},{"key":"10.1002\/14651858.CD012056.pub3-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/ajg.2010.316","article-title":"Outcome in cystic fibrosis liver disease","volume":"106","author":"Rowland","year":"2011","journal-title":"American Journal of Gastroenterology"},{"issue":"2","key":"10.1002\/14651858.CD012056.pub3-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0022-3468(77)80008-0","article-title":"The management of portal hypertension in cystic fibrosis","volume":"12","author":"Schuster","year":"1977","journal-title":"Journal of Pediatric Surgery"},{"issue":"12","key":"10.1002\/14651858.CD012056.pub3-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1001\/archpedi.1991.02160120069022","article-title":"Taurine decreases fecal fatty acid and sterol excretion in cystic fibrosis. A randomized double-blind trial","volume":"145","author":"Smith","year":"1991","journal-title":"American Journal of Diseases of Children"},{"issue":"5","key":"10.1002\/14651858.CD012056.pub3-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1097\/00005176-199805000-00203","article-title":"Does ursodeoxycholic acid improve histological changes in liver disease in cystic fibrosis?","volume":"26","author":"Spray","year":"1998","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"key":"10.1002\/14651858.CD012056.pub3-BIB0034|cit34","unstructured":"Spray C Sinha B Venkataraman M Davies P Ramani P Weller P The role of ursodeoxycholic acid on histological changes in children with cystic fibrosis-liver disease - a prospective study 13th International Cystic Fibrosis Congress; 2000 Jun 4-8; Stockholm, Sweden 2000 132"},{"issue":"8984","key":"10.1002\/14651858.CD012056.pub3-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/S0140-6736(95)92937-1","article-title":"Malabsorption of vitamin E in cystic fibrosis improved after ursodeoxycholic acid","volume":"346","author":"Thomas","year":"1995","journal-title":"Lancet"},{"issue":"4","key":"10.1002\/14651858.CD012056.pub3-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0022-3476(87)80108-7","article-title":"Taurine supplementation, fat absorption, and growth in cystic fibrosis","volume":"111","author":"Thompson","year":"1987","journal-title":"Journal of Pediatrics"},{"issue":"4","key":"10.1002\/14651858.CD012056.pub3-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1093\/ajcn\/46.4.606","article-title":"Protein metabolism in cystic fibrosis: responses to malnutrition and taurine supplementation","volume":"46","author":"Thompson","year":"1987","journal-title":"American Journal of Clinical Nutrition"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD012056.pub3-BIB0038|cit38","first-page":"A118","article-title":"Long-term follow-up of low dose versus high dose ursodeoxycholic acid (UDCA) in cholestasis related to cystic fibrosis (CF)","volume":"39","author":"Meeberg","year":"1996","journal-title":"Gut"},{"issue":"4","key":"10.1002\/14651858.CD012056.pub3-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3109\/00365529709007686","article-title":"Low-dose versus high-dose ursodeoxycholic acid in cystic fibrosis-related cholestatic liver disease. Results of a randomised study with 1- year follow-up","volume":"32","author":"Meeberg","year":"1997","journal-title":"Scandinavian Journal of Gastroenterolology"},{"issue":"Suppl 12","key":"10.1002\/14651858.CD012056.pub3-BIB0040|cit40","first-page":"A39","article-title":"Long-term follow-up of low-dose versus high-dose ursodeoxycholic acid (UDCA) in cystic fibrosis related cholestasis","volume":"8","author":"Meeberg","year":"1996","journal-title":"European Journal of Gastroenterology & Hepatology"},{"issue":"11","key":"10.1002\/14651858.CD012056.pub3-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.3748\/wjg.v18.i11.1166","article-title":"Treatment of portal hypertension","volume":"18","author":"Bari","journal-title":"World J Gastroenterol"},{"issue":"10","key":"10.1002\/14651858.CD012056.pub3-BIB0042|cit42","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1001\/jama.2009.1295","article-title":"Genetic modifiers of liver disease in cystic fibrosis","volume":"302","author":"Bartlett","year":"2009","journal-title":"JAMA"},{"issue":"6","key":"10.1002\/14651858.CD012056.pub3-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1007\/s11938-006-0005-8","article-title":"Liver involvement in cystic fibrosis","volume":"9","author":"Brigman","year":"2006","journal-title":"Current Treatment Options in Gastroenterology"},{"key":"10.1002\/14651858.CD012056.pub3-BIB0044|cit44","unstructured":"Centers for Disease Control and Prevention. National Center for Health Statistics CDC WONDER wonder.cdc.gov\/"},{"issue":"8","key":"10.1002\/14651858.CD012056.pub3-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.3748\/wjg.v9.i8.1836","article-title":"Meta-analysis of propranolol effects on gastrointestinal haemorrhage in cirrhotic patients","volume":"9","author":"Cheng","year":"2003","journal-title":"World Journal of Gastroenterology"},{"issue":"6","key":"10.1002\/14651858.CD012056.pub3-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1002\/hep.1840360613","article-title":"Liver disease in cystic fibrosis: a prospective study on incidence, risk factors, and outcomes","volume":"36","author":"Colombo","year":"2002","journal-title":"Hepatology"},{"issue":"4","key":"10.1002\/14651858.CD012056.pub3-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"571-4","DOI":"10.1542\/peds.80.4.571","article-title":"Orthotopic liver transplantation in cystic fibrosis","volume":"80","author":"Cox","year":"1987","journal-title":"Paediatrics"},{"issue":"5","key":"10.1002\/14651858.CD012056.pub3-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1164\/rccm.200505-840OE","article-title":"Cystic fibrosis since 1938","volume":"173","author":"Davis","year":"2006","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"1","key":"10.1002\/14651858.CD012056.pub3-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jhep.2005.05.009","article-title":"Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension","volume":"43","author":"Franchis","year":"2005","journal-title":"Journal of Hepatology"},{"issue":"1","key":"10.1002\/14651858.CD012056.pub3-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0168-8278(99)80166-4","article-title":"Outcome of cystic fibrosis associated liver cirrhosis: management of portal hypertension","volume":"31","author":"Debray","year":"1999","journal-title":"Journal of Hepatology"},{"key":"10.1002\/14651858.CD012056.pub3-BIB0051|cit51","doi-asserted-by":"publisher","first-page":"S29","DOI":"10.1016\/S1569-1993(11)60006-4","article-title":"Best practice guidance for the diagnosis and management of cystic fibrosis-associated liver disease","volume":"10 Suppl 2","author":"Debray","year":"2011","journal-title":"Journal of Cystic Fibrosis"},{"key":"10.1002\/14651858.CD012056.pub3-BIB0052|cit52","unstructured":"Deeks J Higgins J Altman D editor(s) Chapter 9 Analysing data and undertaking meta-analysis. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"4","key":"10.1002\/14651858.CD012056.pub3-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1111\/j.1600-6143.2011.03904.x","article-title":"Long-term impact of liver transplantation on respiratory function and nutritional status in children and adults with cystic fibrosis","volume":"12","author":"Dowman","year":"2012","journal-title":"American Journal of Transplantation"},{"issue":"1","key":"10.1002\/14651858.CD012056.pub3-BIB0054|cit54","first-page":"332","article-title":"The treatment of portal hypertension: a meta-analytic review","volume":"22","author":"D\u2019Amico","year":"1995","journal-title":"Hepatology"},{"issue":"10","key":"10.1002\/14651858.CD012056.pub3-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1097\/00042737-200310000-00002","article-title":"Liver cirrhosis and portal hypertension in cystic fibrosis","volume":"15","author":"Efrati","year":"2003","journal-title":"European Journal of Gastroenterology & Hepatology"},{"issue":"5","key":"10.1002\/14651858.CD012056.pub3-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.jcf.2008.03.007","article-title":"The prevalence of cystic fibrosis in the European Union","volume":"7","author":"Farrell","year":"2008","journal-title":"Journal of Cystic Fibrosis"},{"issue":"2","key":"10.1002\/14651858.CD012056.pub3-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jcf.2012.11.010","article-title":"Cirrhosis and other liver disease in cystic fibrosis","volume":"12","author":"Flass","year":"2013","journal-title":"Journal of Cystic Fibrosis"},{"issue":"8","key":"10.1002\/14651858.CD012056.pub3-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/S0022-3468(03)00260-4","article-title":"Liver transplantation in children with cystic fibrosis: a long-term longitudinal review of a single centre experience","volume":"38","author":"Fridell","year":"2003","journal-title":"Journal of Pediatric Surgery"},{"issue":"3","key":"10.1002\/14651858.CD012056.pub3-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S1665-2681(19)30934-2","article-title":"Meta-analysis: beta-blockers versus banding ligation for primary prophylaxis of oesophageal variceal bleeding","volume":"11","author":"Funakoshi","year":"2012","journal-title":"Annals of Hepatology"},{"issue":"9","key":"10.1002\/14651858.CD012056.pub3-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1111\/j.1572-0241.2007.01481.x","article-title":"Prevention and management of gastroesophageal varices and variceal haemorrhage in cirrhosis","volume":"102","author":"Garcia-Tsao","year":"2007","journal-title":"American Journal of Gastroenterology"},{"issue":"8","key":"10.1002\/14651858.CD012056.pub3-BIB0061|cit61","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004544.pub2","article-title":"Banding ligation versus beta-blockers for primary prevention in oesophageal varices in adults","author":"Gluud","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"12","key":"10.1002\/14651858.CD012056.pub3-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1002\/lt.20465","article-title":"Variceal haemorrhage and cystic fibrosis: outcomes and implications for liver transplantation","volume":"11","author":"Gooding","year":"2005","journal-title":"Liver Transplantation"},{"issue":"11","key":"10.1002\/14651858.CD012056.pub3-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.3748\/wjg.v18.i11.1176","article-title":"Management of portal hypertension in children","volume":"18","author":"Gugig","year":"2012","journal-title":"World Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD012056.pub3-BIB0064|cit64","unstructured":"Higgins JPT Deeks JJ editor(s) Chapter 7: Selecting studies and collecting data. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011).The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD012056.pub3-BIB0065|cit65","unstructured":"Higgins JPT Altman DG editor(s) Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011).The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD012056.pub3-BIB0066|cit66","unstructured":"Higgins JPT Green S editor(s) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011).The Cochrane Collaboration 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD012056.pub3-BIB0067|cit67","unstructured":"Higgins JPT Deeks JJ Altman DG on behalf of the CSMG Chapter 16: Special topics in statistics. In: Higgins JPT, Green S, editor(s). Cochrane Handbook of Systematic Reviews of Interventions. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"1","key":"10.1002\/14651858.CD012056.pub3-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s00595-007-3576-7","article-title":"Liver transplantation for cystic fibrosis in adults","volume":"38","author":"Ikegami","year":"2008","journal-title":"Surgery Today"},{"issue":"2 Pt 1","key":"10.1002\/14651858.CD012056.pub3-BIB0069|cit69","first-page":"160","article-title":"Incidence and management of complications of injection sclerotherapy: a ten year prospective evaluation","volume":"105","author":"Kahan","year":"1989","journal-title":"Surgery"},{"issue":"5","key":"10.1002\/14651858.CD012056.pub3-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/liv.12113","article-title":"Utility of transient elastography in the non-invasive evaluation of cystic fibrosis liver disease","volume":"33","author":"Kitson","year":"2013","journal-title":"Liver International"},{"issue":"3","key":"10.1002\/14651858.CD012056.pub3-BIB0071|cit71","first-page":"136","article-title":"Liver disease in cystic fibrosis","volume":"9","author":"Kobelska-Dubiel","year":"2014","journal-title":"Przegla\u0328d Gastroenterologiczny"},{"issue":"6","key":"10.1002\/14651858.CD012056.pub3-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.jhep.2004.08.006","article-title":"Epidemiology of liver disease in cystic fibrosis: a longitudinal study","volume":"41","author":"Lamireau","year":"2004","journal-title":"Journal of Hepatology"},{"issue":"12","key":"10.1002\/14651858.CD012056.pub3-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1111\/jgh.12785","article-title":"Cystic fibrosis: an update for clinicians. Part 2: hepatobiliary and pancreatic manifestations","volume":"29","author":"Ledder","year":"2014","journal-title":"Journal of Gastroenterology and Hepatology"},{"key":"10.1002\/14651858.CD012056.pub3-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/hep.510300527","article-title":"Natural history of liver disease in cystic fibrosis","volume":"30","author":"Lindblad","year":"1999","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD012056.pub3-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1002\/ppul.20713","article-title":"Partial splenectomy for portal hypertension in cystic fibrosis related liver disease","volume":"42","author":"Louis","year":"2007","journal-title":"Pediatric Pulmonology"},{"key":"10.1002\/14651858.CD012056.pub3-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1111\/j.1399-3046.2010.01412.x","article-title":"A review of abdominal organ transplantation in patients with cystic fibrosis","volume":"14","author":"Lu","year":"2010","journal-title":"Pediatric Transplantation"},{"issue":"6","key":"10.1002\/14651858.CD012056.pub3-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"881-7","DOI":"10.1016\/S0022-3476(95)70022-6","article-title":"Clinical denouement and mutation analysis of patients with cystic fibrosis undergoing liver transplantation for biliary cirrhosis","volume":"127","author":"Mack","year":"1995","journal-title":"Journal of Pediatrics"},{"issue":"5","key":"10.1002\/14651858.CD012056.pub3-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.jcf.2011.04.004","article-title":"Transient elastography and portal hypertension in paediatric patient with cystic fibrosis","volume":"10","author":"Malbrunot-Wagner","year":"2011","journal-title":"Journal of Cystic Fibrosis"},{"issue":"9","key":"10.1002\/14651858.CD012056.pub3-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/j.1432-2277.2006.00344.x","article-title":"Liver transplant in cystic fibrosis: a poll among European centre. A study from the European Liver Transplant Registry","volume":"19","author":"Melzi","year":"2006","journal-title":"Transplant International"},{"key":"10.1002\/14651858.CD012056.pub3-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/lt.22240","article-title":"Liver transplantation in patients with cystic fibrosis: analysis of United Network for Organ Sharing data","volume":"17","author":"Mendizabal","year":"2011","journal-title":"Liver Transplantation"},{"issue":"7","key":"10.1002\/14651858.CD012056.pub3-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1007\/s00247-009-1531-z","article-title":"Transient elastography in patient with cystic fibrosis","volume":"40","author":"Menten","year":"2010","journal-title":"Pediatric Radiology"},{"issue":"1","key":"10.1002\/14651858.CD012056.pub3-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s11894-010-0151-y","article-title":"Management of portal hypertension in children","volume":"13","author":"Mileti","year":"2011","journal-title":"Current Gastroenterology Reports"},{"issue":"2","key":"10.1002\/14651858.CD012056.pub3-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1046\/j.1440-1746.2002.02671.x","article-title":"Transplantation for cystic fibrosis: outcome following early liver transplantation","volume":"17","author":"Milkiewicz","year":"2012","journal-title":"Journal of Gastroenterology and Hepatology"},{"issue":"3","key":"10.1002\/14651858.CD012056.pub3-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/MOG.0b013e3283298865","article-title":"Hepatobiliary disease in patients with cystic fibrosis","volume":"25","author":"Moyer","year":"2009","journal-title":"Current Opinion in Gastroenterology"},{"issue":"8677","key":"10.1002\/14651858.CD012056.pub3-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/S0140-6736(89)92035-7","article-title":"Liver disease and bile duct abnormalities in adult with cystic fibrosis","volume":"2","author":"Nagel","year":"1989","journal-title":"Lancet"},{"issue":"1","key":"10.1002\/14651858.CD012056.pub3-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1600-6143.2007.02028.x","article-title":"Cystic fibrosis liver disease: to transplant or not to transplant?","volume":"8","author":"Nash","year":"2008","journal-title":"American Journal of Transplantation"},{"key":"10.1002\/14651858.CD012056.pub3-BIB0087|cit87","first-page":"31-7","article-title":"Liver transplantation for hepatic cirrhosis in cystic fibrosis","volume":"89 Suppl 27","author":"Noble-Jamieson","year":"1996","journal-title":"Journal of the Royal Society of Medicine"},{"key":"10.1002\/14651858.CD012056.pub3-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0022-3476(85)80316-4","article-title":"Propranolol therapy for portal hypertension in children","volume":"106","author":"Ozsoylu","year":"1985","journal-title":"Journal of Pediatrics"},{"issue":"1","key":"10.1002\/14651858.CD012056.pub3-BIB0089|cit89","first-page":"31","article-title":"Propranolol for primary and secondary prophylaxis of variceal bleeding in children with cirrhosis","volume":"42","author":"Ozsoylu","year":"2000","journal-title":"Turkish Journal of Pediatrics"},{"issue":"52","key":"10.1002\/14651858.CD012056.pub3-BIB0090|cit90","first-page":"1111","article-title":"Transjugular intrahepatic portosystemic shunt in five children with cystic fibrosis: long term results","volume":"50","author":"Pozler","year":"2003","journal-title":"Hepatogastroenterology"},{"issue":"8","key":"10.1002\/14651858.CD012056.pub3-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/S0022-3468(96)90086-X","article-title":"Management of oesophageal varices in children by endoscopic variceal ligation","volume":"31","author":"Price","year":"1996","journal-title":"Journal of Pediatric Surgery"},{"issue":"6","key":"10.1002\/14651858.CD012056.pub3-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1378\/chest.08-1190","article-title":"Determination of the minimal clinically important difference scores for the Cystic Fibrosis Questionnaire-Revised respiratory symptom scale in two populations of patients with cystic fibrosis and chronic Pseudomonas aeruginosa airway infection","volume":"135","author":"Quittner","year":"2009","journal-title":"Chest"},{"key":"10.1002\/14651858.CD012056.pub3-BIB0093|cit93","unstructured":"Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"key":"10.1002\/14651858.CD012056.pub3-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/ajg.2010.316","article-title":"Outcome in cystic fibrosis liver disease","volume":"106","author":"Rowland","year":"2011","journal-title":"American Journal of Gastroenterology"},{"issue":"3","key":"10.1002\/14651858.CD012056.pub3-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1155\/2015\/138530","article-title":"Non invasive methods, including transient elastrography, for the detection of liver disease in adults with cystic fibrosis","volume":"29","author":"Sadler","year":"2015","journal-title":"Canadian Journal of Gastroenterology and Hepatology"},{"issue":"1","key":"10.1002\/14651858.CD012056.pub3-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/00005176-199907000-00007","article-title":"Propranolol in prevention of portal hypertensive haemorrhage in children: a pilot study","volume":"29","author":"Shashidhar","year":"1999","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"issue":"5","key":"10.1002\/14651858.CD012056.pub3-BIB0097|cit97","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1111\/j.1399-3046.2012.01652.x","article-title":"Portal hypertension in children: expert paediatric opinion on the report of the Baveno v Consensus Workshop on Methodology of Diagnosis and Therapy in Portal Hypertension","volume":"16","author":"Shneider","year":"2012","journal-title":"Pediatric Transplantation"},{"issue":"4","key":"10.1002\/14651858.CD012056.pub3-BIB0098|cit98","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.rmed.2008.10.011","article-title":"Growing old with cystic fibrosis - the characteristics of long-term survivors of cystic fibrosis","volume":"103","author":"Simmonds","year":"2009","journal-title":"Respiratory Medicine"},{"issue":"6","key":"10.1002\/14651858.CD012056.pub3-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1002\/hep.20238","article-title":"Endogenous ursodeoxycholic acid and cholic acid in liver disease due to cystic fibrosis","volume":"39","author":"Smith","year":"2004","journal-title":"Hepatology"},{"key":"10.1002\/14651858.CD012056.pub3-BIB0100|cit100","unstructured":"Sterne J Egger M Moher D editor(s) Chapter 10: Addressing reporting biases. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"3","key":"10.1002\/14651858.CD012056.pub3-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1136\/adc.69.3.407","article-title":"Liver cirrhosis in cystic fibrosis","volume":"69","author":"Stringer","year":"1993","journal-title":"Archives of Disease in Childhood"},{"key":"10.1002\/14651858.CD012056.pub3-BIB0102|cit102","unstructured":"World Health Organization (Genomic Resource Centre) Genes and human disease www.who.int\/genomics\/public\/geneticdiseases\/en\/index2.html"},{"issue":"6","key":"10.1002\/14651858.CD012056.pub3-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.jcf.2009.08.001","article-title":"Non-invasive liver elastography (Fibroscan) for detection of cystic fibrosis-associated liver disease","volume":"8","author":"Witters","year":"2009","journal-title":"Journal of Cystic Fibrosis"},{"issue":"3","key":"10.1002\/14651858.CD012056.pub3-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00423-003-0367-5","article-title":"Current state of portosystemic shunt surgery","volume":"388","author":"Wolff","year":"2003","journal-title":"Langenbeck's Archives of Surgery"},{"key":"10.1002\/14651858.CD012056.pub3-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1055\/s-2000-9617","article-title":"A prospective, randomised comparison of the ease and safety of variceal ligation using a multiband vs. a conventional ligation device","volume":"32","author":"Wong","year":"2000","journal-title":"Endoscopy"},{"issue":"8","key":"10.1002\/14651858.CD012056.pub3-BIB0106|cit106","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012056.pub2","article-title":"Interventions for preventing and managing advanced liver disease in cystic fibrosis","author":"Palaniappan","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T04:19:43Z","timestamp":1695961183000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD012056.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Cystic Fibrosis and Genetic Disorders Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2020,3,30]]},"references-count":106,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,3]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd012056.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,30]]}}}